[Integration of G-CSF in prevention and therapy of neutropenic fever].
Siegmund
R
R
Innere Medizin II, Städtische Kliniken Oldenburg.
Illiger
H J
HJ
D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005335:Fever of Unknown Origin / Q000209:etiology / Q000628:therapy*; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage* / Q000009:adverse effects; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D009503:Neutropenia / Q000209:etiology / Q000628:therapy*; D009894:Opportunistic Infections / Q000209:etiology / Q000628:therapy*
D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor